Schedule 13D ownership disclosure

Erytech Pharma S.A.

Security class unavailable · CUSIP: 29604W108

Event date: 2018-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-037011
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Jul 02, 2018
Reporting period
Jun 28, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub